Grufity logoGrufity logo

ZBH

122.97USD-0.38(-0.31%)Market Closed

Zimmer Biomet Holdings Inc

Market Summary

USD122.97-0.38Market Closed
-0.31%

ZBH Alerts

ZBH Stock Price

RSI Chart

Valuation

Market Cap

23.8B

Price/Earnings

103.74

Price/Sales

3.21

Price/Cashflow

16.31

MarketCap/EBT

73.35

Price/Sales

Profitability

EBT Margin

4.38%

Return on Equity

1.89%

Return on Assets

1.07%

Fundamentals

Revenue

Revenue (TTM)

7.2B

Revenue Y/Y

-13.21%

Revenue Q/Q

-6.29%

Earnings

Earnings (TTM)

277.9M

Earnings Y/Y

33.24%

Earnings Q/Q

26.22%

Price Action

52 Week Range

134.75
(Low)(High)

Last 7 days

3.2%

Last 30 days

14.2%

Last 90 days

16.5%

Trailing 12 Months

3.2%

Financial Health

Current Ratio

1.81

Debt/Equity

0.46

Debt/Cashflow

0.26

Investor Care

Dividend Yield

0.84%

Dividend/Share (TTM)

0.95

Buy Backs (1Y)

2.04%

Diluted EPS (TTM)

1.38

Peers (Alternatives to Zimmer Biomet Holdings)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
10.2T
429.9M
-11.88% 44.84%
185.5K
28.0K
144.70% 331.94%
115.4B
30.8B
-7.18% -24.29%
22.17
3.71
-3.11% -8.14%
86.7B
17.9B
14.69% -0.88%
41.71
4.92
7.67% 29.32%
86.3B
6.1B
15.30% -16.82%
62.6
14.1
11.47% -18.42%
67.1B
18.9B
10.69% 8.01%
38.21
3.25
-6.81% -14.96%
43.9B
5.4B
8.87% -30.30%
30.09
8.18
5.29% -1.25%
MID-CAP
6.7B
998.4M
15.24% 17.79%
44.21
6.87
6.04% -19.01%
6.4B
806.4M
33.98% -14.84%
-331.15
7.96
20.10% -221.96%
3.9B
380.1M
-8.48% 5.83%
-29.57
10.69
18.85% -63.58%
3.6B
790.7M
-16.73% -66.49%
-273.58
4.7
19.65% -412.22%
SMALL-CAP
1.6B
126.8M
26.44% 24.39%
-26.38
14.01
34.44% -10.05%
1.0B
795.9M
17.05% -10.97%
-131.34
1.33
8.11% 182.50%
994.0M
154.8M
-8.78% -40.92%
-10.57
6.72
60.29% -2309.58%
606.7M
236.2M
-6.64% -29.40%
-16.43
2.57
-8.79% -175.19%

Financials for Zimmer Biomet Holdings

Income Statement (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Revenue-3.4%7,1537,4077,6527,8367,638
  S&GA Expenses-5.6%2,4882,6362,6372,8432,585
Earnings Before Taxes4.6%340325299418746
Net Income21.1%278230218402819
Balance Sheet
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Assets-0.6%21,33321,45321,61823,45624,009
  Current Assets1.6%4,5344,4634,5174,8855,312
    Cash Equivalents41.1%545386436378920
  Inventory0.3%2,1292,1232,1322,1482,517
  Net PPE0.3%1,8021,7971,8262,0172,008
  Goodwill-0.8%8,7998,8698,8968,9199,212
Liabilities-2.6%9,0829,3289,59610,79011,294
  Current Liabilities-6.8%2,2962,4642,6743,4682,939
  Long Term Debt-5.3%5,2635,5605,9957,2167,857
    LT Debt, Current-22.6%6598521,0151,6051,046
    LT Debt, Non Current-2.3%5,0555,1725,2865,4646,458
Shareholder's Equity1.0%12,24512,11812,01612,66112,709
  Retained Earnings1.4%9,7409,6079,50310,29210,426
  Additional Paid-In Capital0.4%9,4199,3869,3159,295-
Accumulated Depreciation0.1%4,5434,5404,4424,3014,629
Shares Outstanding0.2%210209214--
Minority Interest3.2%66666
* denotes actual numbers (not divided by Millions)
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Cashflow From Operations1.2%1,4781,4601,5681,4991,559
  Share Based Compensation2.3%9694878585
Cashflow From Investing6.7%-555.70-595.70-462.40-503.60-673.30
Cashflow From Financing17.2%-1,118.10-1,350.30-1,232.60-1,306.00-936.50
  Dividend Payments0.1%201201200200

Risks

What is the probability of a big loss on ZBH?

66.9%


Probability that Zimmer Biomet Holdings stock will be more than 20% underwater in next one year

34.6%


Probability that Zimmer Biomet Holdings stock will be more than 30% underwater in next one year.

18.5%


Probability that Zimmer Biomet Holdings stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does ZBH drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Zimmer Biomet Holdings was unfortunately bought at previous high price.

Returns

Cumulative Returns on ZBH

7.6%


10-Year Cumulative Returns

4.1%


7-Year Cumulative Returns

2.7%


5-Year Cumulative Returns

-3.5%


3-Year Cumulative Returns

What are the long-term rolling returns for ZBH?

FIve years rolling returns for Zimmer Biomet Holdings.

Which funds bought or sold ZBH recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2022-11-29
Bridgefront Capital, LLC
NEW
-
519,000
519,000
0.53%
2022-11-23
Toroso Investments, LLC
ADDED
16.73
416,000
2,992,000
0.12%
2022-11-23
Eagle Bay Advisors LLC
UNCHANGED
-
475
1,000
-%
2022-11-23
Gould Capital, LLC
UNCHANGED
-
-
1,000
-%
2022-11-22
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY
NEW
-
2,086,000
2,086,000
0.02%
2022-11-22
B. Riley Wealth Advisors, Inc.
ADDED
0.69
-1,000
366,000
0.01%
2022-11-22
CVA Family Office, LLC
-
-
-17,000
9,000
-%
2022-11-21
FourThought Financial, LLC
-
-
-1,000
63,000
0.01%
2022-11-21
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
-
-
-497,000
36,302,000
0.06%
2022-11-21
ST GERMAIN D J CO INC
-
-
-
7,417,000
0.49%

1–10 of 44

Latest Funds Activity

Are funds buying ZBH calls or puts?
Are funds bullish or bearish(Calls - Puts)?
No. of funds that own ZBH

Zimmer Biomet Holdings News

Simply Wall St

Should You Think About Buying Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Now?.40 hours ago

ZBH Fair Value

Recent SEC filings of Zimmer Biomet Holdings

View All Filings
Date Filed Form Type Document
Nov 07, 2022
SC 13G/A
Major Ownership Report
Nov 02, 2022
10-Q
Quarterly Report
Nov 02, 2022
8-K
Current Report
Oct 04, 2022
4
Insider Trading
Oct 04, 2022
4
Insider Trading
Oct 04, 2022
4
Insider Trading
Oct 04, 2022
4
Insider Trading
Oct 04, 2022
4
Insider Trading
Oct 04, 2022
4
Insider Trading
Oct 04, 2022
4
Insider Trading

Latest Insider Trading transactions for ZBH

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2022-07-05
VAN ZUILEN WILFRED
SOLD
-55,870.2
105.217
-531
Pres, Europe, M. East & Africa
2022-07-01
VAN ZUILEN WILFRED
ACQUIRED
-
-
2,633
Pres, Europe, M. East & Africa
2022-07-01
Upadhyay Suketu
SOLD (Taxes)
-132,207
105.85
-1,249
Exec. VP, CFO
2022-07-01
Upadhyay Suketu
ACQUIRED
-
-
3,768
Exec. VP, CFO
2022-05-01
Ellingson Rachel
SOLD (Taxes)
-20,445.8
122.43
-167
SVP & Chief Strategy Officer
2022-05-01
Ellingson Rachel
ACQUIRED
-
-
531
SVP & Chief Strategy Officer
2022-03-17
Phipps Chad F
ACQUIRED
2,186,970
62.22
35,149
Sr. VP/Gen Counsel/Secretary
2022-03-17
Phipps Chad F
SOLD
-4,287,250
121.974
-35,149
Sr. VP/Gen Counsel/Secretary
2022-03-10
Winkler Lori
SOLD (Taxes)
-8,000.2
123.08
-65
SVP and CHRO
2022-03-02
Winkler Lori
ACQUIRED
-
-
181
SVP and CHRO

1–10 of 50

Bryan C. Hanson
19500
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest toss facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as robotic, surgical and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

ZBH Income Statement

2022-09-30
Condensed Consolidated Statements of Earnings (unaudited) - USD ($)
shares in Millions, $ in Millions
3 Months Ended9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Income Statement [Abstract]    
Net Sales$ 1,669.8$ 1,685.4$ 5,114.8$ 5,050.1
Type of Revenue [Extensible List]us-gaap:ProductMemberus-gaap:ProductMemberus-gaap:ProductMemberus-gaap:ProductMember
Cost of products sold, excluding intangible asset amortization$ 488.2$ 491.4$ 1,499.2$ 1,423.9
Type of Cost, Good or Service [Extensible List]us-gaap:ProductMemberus-gaap:ProductMemberus-gaap:ProductMemberus-gaap:ProductMember
Intangible asset amortization$ 131.5$ 132.2$ 395.3$ 398.7
Research and development101.793.8298.0339.8
Selling, general and administrative654.9684.42,034.62,038.2
Intangible asset impairment  3.016.3
Restructuring and other cost reduction initiatives28.322.5129.262.6
Quality remediation8.111.722.432.8
Acquisition, integration, divestiture and related11.86.48.511.3
Operating expenses, net1,424.51,442.44,390.24,323.6
Operating Profit245.3243.0724.6726.5
Other (expense) income, net(25.4)0.3(124.1)16.0
Interest expense, net(42.3)(52.6)(122.2)(159.6)
Earnings from continuing operations before income taxes177.6190.7478.3582.9
(Benefit) Provision for income taxes from continuing operations(16.6)28.356.982.7
Net Earnings from continuing operations194.2162.4421.4500.2
Less: Net earnings attributable to noncontrolling interest0.20.20.70.4
Net Earnings from Continuing Operations of Zimmer Biomet Holdings, Inc.194.0162.2420.7499.8
Loss from discontinued operations, net of taxes (16.6)(58.8)(14.2)
Net Earnings of Zimmer Biomet Holdings, Inc.$ 194.0$ 145.6$ 361.9$ 485.6
Earnings Per Common Share - Basic    
Earnings from continuing operations$ 0.92$ 0.78$ 2.01$ 2.40
Loss from discontinued operations (0.08)(0.28)(0.07)
Net Earnings Per Common Share - Basic0.920.701.732.33
Earnings Per Common Share - Diluted    
Earnings from continuing operations0.920.772.002.37
Loss from discontinued operations (0.08)(0.28)(0.06)
Net Earnings Per Common Share - Diluted$ 0.92$ 0.69$ 1.72$ 2.31
Weighted Average Common Shares Outstanding    
Basic209.8208.8209.5208.5
Diluted210.3210.6210.2210.5

ZBH Balance Sheet

2022-09-30
Condensed Consolidated Balance Sheets (unaudited) - USD ($)
$ in Millions
Sep. 30, 2022
Dec. 31, 2021
Current Assets:  
Cash and cash equivalents$ 545.4$ 378.1
Accounts receivable, less allowance for credit losses1,278.51,259.6
Inventories2,128.62,148.0
Prepaid taxes234.6326.7
Prepaid expenses and other current assets347.3271.0
Current assets of discontinued operations 501.6
Total Current Assets4,534.44,885.0
Property, plant and equipment, net1,801.61,836.6
Goodwill8,798.88,919.4
Intangible assets, net5,136.55,533.6
Other assets1,062.01,005.0
Noncurrent assets of discontinued operations 1,276.8
Total Assets21,333.323,456.4
Current Liabilities:  
Accounts payable333.9306.5
Income taxes payable30.462.0
Customer rebates115.9129.5
Other current liabilities1,156.41,187.6
Current portion of long-term debt659.11,605.1
Current liabilities of discontinued operations 177.2
Total Current Liabilities2,295.73,467.9
Deferred income taxes, net541.3558.5
Long-term income tax payable581.3583.0
Other long-term liabilities608.7548.5
Long-term debt5,055.25,463.7
Noncurrent liabilities of discontinued operations 168.4
Total Liabilities9,082.210,790.0
Commitments and Contingencies (Note 16)
Stockholders' Equity:  
Common stock, $0.01 par value, one billion shares authorized, 313.6 million shares in 2022 (312.8 million in 2021) issued3.13.1
Paid-in capital9,463.99,314.8
Retained earnings9,739.910,292.2
Accumulated other comprehensive loss(244.9)(231.6)
Treasury stock, 103.8 million shares in 2022 and 2021(6,717.3)(6,717.8)
Total Zimmer Biomet Holdings, Inc. stockholders' equity12,244.712,660.7
Noncontrolling interest6.45.7
Total Stockholders' Equity12,251.112,666.4
Total Liabilities and Stockholders' Equity$ 21,333.3$ 23,456.4